NEW YORK (GenomeWeb) – OvaGene Oncology announced today that it has acquired Etta Healthcare, combining its liquid biopsy and molecular diagnostics with Etta's point-of-care system to provide doctors with easy-to-use, rapid, point-of-care molecular tests.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.